ATE54441T1 - Naphthalenderivate, ihr herstellungsverfahren und pharmazeutische zusammensetzungen davon und diese enthaltende pharmazeutische zusammensetzungen. - Google Patents
Naphthalenderivate, ihr herstellungsverfahren und pharmazeutische zusammensetzungen davon und diese enthaltende pharmazeutische zusammensetzungen.Info
- Publication number
- ATE54441T1 ATE54441T1 AT86100282T AT86100282T ATE54441T1 AT E54441 T1 ATE54441 T1 AT E54441T1 AT 86100282 T AT86100282 T AT 86100282T AT 86100282 T AT86100282 T AT 86100282T AT E54441 T1 ATE54441 T1 AT E54441T1
- Authority
- AT
- Austria
- Prior art keywords
- sup
- pharmaceutical compositions
- formula
- naphthalene derivatives
- compounds
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical class C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 150000002790 naphthalenes Chemical class 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 206010003210 Arteriosclerosis Diseases 0.000 abstract 1
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000055 hyoplipidemic effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/94—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/92—Naphthofurans; Hydrogenated naphthofurans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
- C07C63/33—Polycyclic acids
- C07C63/337—Polycyclic acids with carboxyl groups bound to condensed ring systems
- C07C63/34—Polycyclic acids with carboxyl groups bound to condensed ring systems containing two condensed rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
- C07C65/24—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Fats And Perfumes (AREA)
- Lubricants (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP309085 | 1985-01-10 | ||
| EP86100282A EP0188248B1 (en) | 1985-01-10 | 1986-01-10 | Naphthalene derivatives, process for the preparation thereof and pharmaceutical composition containing same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE54441T1 true ATE54441T1 (de) | 1990-07-15 |
Family
ID=11547645
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT86100282T ATE54441T1 (de) | 1985-01-10 | 1986-01-10 | Naphthalenderivate, ihr herstellungsverfahren und pharmazeutische zusammensetzungen davon und diese enthaltende pharmazeutische zusammensetzungen. |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US4771072A (OSRAM) |
| EP (1) | EP0188248B1 (OSRAM) |
| JP (3) | JPS61267541A (OSRAM) |
| KR (1) | KR890001884B1 (OSRAM) |
| CN (1) | CN1006464B (OSRAM) |
| AT (1) | ATE54441T1 (OSRAM) |
| AU (1) | AU584153B2 (OSRAM) |
| BG (2) | BG45385A3 (OSRAM) |
| DD (1) | DD270529A5 (OSRAM) |
| DE (1) | DE3672501D1 (OSRAM) |
| ES (2) | ES8705837A1 (OSRAM) |
| FI (1) | FI87557C (OSRAM) |
| HU (1) | HU196737B (OSRAM) |
| IL (1) | IL91117A0 (OSRAM) |
| MY (1) | MY101268A (OSRAM) |
| NO (1) | NO170760C (OSRAM) |
| PH (1) | PH22105A (OSRAM) |
| PT (1) | PT81814B (OSRAM) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5011948A (en) * | 1985-04-12 | 1991-04-30 | Bristol-Myers Company | Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof |
| US4644072A (en) * | 1985-04-12 | 1987-02-17 | Bristol-Myers Company | Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof |
| JPS6310746A (ja) * | 1986-07-01 | 1988-01-18 | Tanabe Seiyaku Co Ltd | ナフタレン誘導体 |
| AT388372B (de) * | 1987-10-08 | 1989-06-12 | Tanabe Seiyaku Co | Neue naphthalinderivate und sie enthaltende pharmazeutika |
| JPH01135766A (ja) * | 1987-11-20 | 1989-05-29 | Tanabe Seiyaku Co Ltd | ビフェニル誘導体 |
| PH26342A (en) * | 1988-11-29 | 1992-04-29 | Univ Texas | Microbial cellulose modified during synthesis |
| MY105057A (en) * | 1989-01-27 | 1994-07-30 | Tanabe Seiyaku Co | A process for preparing naphthalene derivatives |
| US5003087A (en) * | 1989-02-03 | 1991-03-26 | Tanabe Seiyaku Co., Ltd. | Process for preparing a naphthalene derivative and a synthetic intermediate thereof |
| EP0501578A1 (en) * | 1991-02-28 | 1992-09-02 | Merck Frosst Canada Inc. | Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis |
| US5227399A (en) * | 1991-02-28 | 1993-07-13 | Merck Frosst Canada, Inc. | Pyranylphenyl naphthalene lactones as inhibitors of leukotriene biosynthesis |
| EP0501579A1 (en) * | 1991-02-28 | 1992-09-02 | Merck Frosst Canada Inc. | Naphthalene lactones as inhibitors of leukotriene biosynthesis |
| US5281720A (en) * | 1991-02-28 | 1994-01-25 | Merck Frosst Canada, Inc. | Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis |
| JP2839805B2 (ja) * | 1991-10-17 | 1998-12-16 | 塩野義製薬株式会社 | リグナン類縁体及びその製造方法ならびに抗高脂血症剤 |
| US5308852A (en) * | 1992-06-29 | 1994-05-03 | Merck Frosst Canada, Inc. | Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis |
| US5428060A (en) * | 1992-08-27 | 1995-06-27 | Merck Frosst Canada, Inc. | Heteroarylnaphthalene lactones as inhibitors of leukotriene biosynthesis |
| US5350744A (en) * | 1992-08-27 | 1994-09-27 | Merck Frosst Canada, Inc. | Phenylnaphthalene lactones as inhibitors of leukotriene biosynthesis |
| US5252599A (en) * | 1992-08-27 | 1993-10-12 | Merck Frosst Canada, Inc. | Heteroarylnaphthalene hydroxy acids as inhibitors of leukotriene biosynthesis |
| US5426109A (en) * | 1992-08-27 | 1995-06-20 | Merck Frosst Canada, Inc. | Phenylnaphthalene hydroxy acids |
| CA2121060C (en) * | 1993-04-16 | 2004-04-06 | Sachio Mori | Preparation of lignan analogues |
| ID18046A (id) * | 1996-08-20 | 1998-02-19 | Takeda Chemical Industries Ltd | Senyawa siklik campuran, pembuatan dan penngunaannya. |
| BR9913333A (pt) * | 1998-08-25 | 2001-05-15 | Univ Yale | Inibição e tratamento do vìrus da hepatite b e flavivìrus com helioxatina e seus análogos |
| US6680344B1 (en) | 1999-06-01 | 2004-01-20 | The University Of Texas Southwestern Medical Center | Method of treating hair loss using diphenylmethane derivatives |
| AR018699A1 (es) | 1999-06-01 | 2001-11-28 | Procter & Gamble | Metodo para el tratamiento de la perdida del cabello el cual comprende administrar una composicion que comprende un compuesto el cual no afecta al corazon |
| AU3507700A (en) | 1999-06-01 | 2000-12-18 | University Of Texas Southwestern Medical Center, The | Method of treating hair loss using diphenylether derivatives |
| SE0102168D0 (sv) * | 2001-06-19 | 2001-06-19 | Karolinska Innovations Ab | New use and new compounds |
| NZ531346A (en) * | 2001-08-28 | 2005-10-28 | Sankyo Co | Medicinal compositions containing angiotensin II receptor antagonist |
| GB0307918D0 (en) | 2003-04-05 | 2003-05-14 | Astrazeneca Ab | Therapeutic use |
| EP4137137A1 (en) | 2010-05-26 | 2023-02-22 | Satiogen Pharmaceuticals, Inc. | Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions |
| MX363161B (es) | 2011-10-28 | 2019-03-13 | Lumena Pharmaceuticals Inc | Inhibidores de la recirculación de ácidos biliares para el tratamiento de hipercolemia y enfermedad hepática colestásica. |
| WO2013063512A1 (en) | 2011-10-28 | 2013-05-02 | Lumena Pharmaceuticals, Inc | Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases |
| MX2015013196A (es) | 2013-03-15 | 2016-04-15 | Lumena Pharmaceuticals Inc | Inhibidores de reciclaje de acidos biliares para el tratamiento de la enfermedad de reflujo gastroesofagico y esofago de barrett. |
| EP2968230A2 (en) | 2013-03-15 | 2016-01-20 | Lumena Pharmaceuticals, Inc. | Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease |
| US20170119806A1 (en) * | 2014-03-31 | 2017-05-04 | Ohio State Innovation Foundation | Arylnaphthalene lactone derivatives and methods of making and using thereof |
| US10682367B2 (en) | 2016-02-26 | 2020-06-16 | Ohio State Innovation Foundation | Antitumor arylnaphthalene ligand glycosides |
| PT3923943T (pt) | 2019-02-12 | 2024-10-23 | Mirum Pharmaceuticals Inc | Resposta dependente da dose e do genótipo a um asbti em doentes com deficiência na bomba de exportação de sais biliares |
-
1985
- 1985-12-30 US US06/814,805 patent/US4771072A/en not_active Expired - Fee Related
- 1985-12-30 ES ES550578A patent/ES8705837A1/es not_active Expired
- 1985-12-30 NO NO855355A patent/NO170760C/no unknown
- 1985-12-31 AU AU51751/85A patent/AU584153B2/en not_active Ceased
-
1986
- 1986-01-08 PH PH33266A patent/PH22105A/en unknown
- 1986-01-08 JP JP61002624A patent/JPS61267541A/ja active Pending
- 1986-01-09 PT PT81814A patent/PT81814B/pt not_active IP Right Cessation
- 1986-01-09 BG BG082397A patent/BG45385A3/xx unknown
- 1986-01-09 FI FI860089A patent/FI87557C/fi not_active IP Right Cessation
- 1986-01-09 HU HU8690A patent/HU196737B/hu not_active IP Right Cessation
- 1986-01-09 BG BG073061A patent/BG45383A3/xx unknown
- 1986-01-09 KR KR1019860000074A patent/KR890001884B1/ko not_active Expired
- 1986-01-10 EP EP86100282A patent/EP0188248B1/en not_active Expired - Lifetime
- 1986-01-10 DE DE8686100282T patent/DE3672501D1/de not_active Expired - Lifetime
- 1986-01-10 AT AT86100282T patent/ATE54441T1/de not_active IP Right Cessation
- 1986-01-10 CN CN86100090A patent/CN1006464B/zh not_active Expired
- 1986-09-03 ES ES557052A patent/ES8801239A1/es not_active Expired
-
1987
- 1987-07-15 MY MYPI87001017A patent/MY101268A/en unknown
-
1988
- 1988-01-15 DD DD88312249A patent/DD270529A5/de not_active IP Right Cessation
- 1988-12-08 JP JP63310354A patent/JPH0272170A/ja active Granted
- 1988-12-08 JP JP63310353A patent/JPH0272136A/ja active Pending
-
1989
- 1989-07-26 IL IL91117A patent/IL91117A0/xx unknown
-
1990
- 1990-01-02 US US07/459,859 patent/US5070103A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE54441T1 (de) | Naphthalenderivate, ihr herstellungsverfahren und pharmazeutische zusammensetzungen davon und diese enthaltende pharmazeutische zusammensetzungen. | |
| DE3773546D1 (de) | Naphthalenderivate, ihr herstellungsverfahren und diese enthaltende pharmazeutische zusammensetzungen. | |
| MY102016A (en) | Thiazolidinedione derivatives, their production and use. | |
| GEP20043160B (en) | Biaryl Ether Derivatives, Pharmaceutical Compositions Containing Them and Their Use as Monoamine Reuptake Inhibitors | |
| DE69132167D1 (de) | Kondensierte benzoxa-ringverbindung, deren herstellung sowie diese enthaltendes arzneimittel | |
| HUT45230A (en) | Process for producing new phenoxy-acetic acid derivatives and pharmaceuticals comprising such compounds | |
| WO1994014833A3 (en) | Substituted 6-azaandrostenones | |
| HUT70548A (en) | Oxazolidone derivatives, process for producing them and pharmaceutical compositions containing them | |
| CA2053477A1 (en) | Heterocyclic amine derivatives, their production and use | |
| DE3683822D1 (de) | Chartreusinderivate und salze, diese enthaltende antitumorzusammensetzungen und verfahren zu ihrer herstellung. | |
| ATE48994T1 (de) | Benzimidazol-derivat, verfahren zu seiner herstellung und pharmazeutische zusammensetzung. | |
| ES8104269A1 (es) | Procedimiento para la preparacion de nuevos derivados de 3-amino-1-benzoxepina | |
| EP0316939A3 (en) | Biphenyl derivatives, preparation method, pharmaceutical compositions comprising them and use | |
| JPH01104064A (ja) | 塩基性に置換されたベンゾフランカルボン酸アミド、この化合物の製法及びこれを含有する医薬 | |
| GR860045B (en) | Novel piperazine derivatives processes for production thereof and pharmaceutical compositions comprising said compounds as active ingredient | |
| ES2059572T3 (es) | Derivado del antibiotico a 42867. | |
| US3868463A (en) | Method of treating arrhythmia | |
| ES374762A1 (es) | Procedimiento para la preparacion de derivado de benzo (b) benzofurano (2,3-e) oxapina. | |
| US3028306A (en) | Hypertensive 2-amino-3alpha, 4, 5, 6, 7, 7alpha-hexahydrobenzoxazole method and topical dosage preparation | |
| JPS5695188A (en) | Theophyllin derivative and its production | |
| US3873601A (en) | Anesthetic compounds | |
| DK644487D0 (da) | Farmaceutisk praeparat indeholdende en 2-oxo-imidazolidinforbindelse | |
| GB1110858A (en) | Improvements in and relating to new sulphonamides,the process of preparation and theapplications thereof | |
| RU94031211A (ru) | Производные изатина, способ их получения и фармацевтическая композиция на их основе | |
| JO1672B1 (en) | Dialoxy-pyridinyl-benzimidazole derivatives and a way to prepare and use it in a pharmacy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |